Medical Condition News

RSS

Study to develop ways to track individual's exposure to traffic pollution

Researchers at King's College London are developing ways of working out a person's individual exposure to traffic pollution when travelling to, from, and around London.

9 Dec 2010

Collegium Ramazzini repeats calls for total global ban on all asbestos

Scientists at the Collegium Ramazzini in Modena, Italy have repeated calls for a total ban on all asbestos across the globe. Writing in the International Journal of Environment and Health, the Collegium points out that just 52 nations have banned asbestos but a large number still use, import and export asbestos and asbestos-containing products.

9 Dec 2010

Zealand receives EUR 500,000 milestone payment from Helsinn Healthcare for ZP1846 development program

Zealand Pharma, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs that recently listed on NASDAQ OMX, today announces the receipt of a EUR 500,000 (DKK 3.73 million) milestone payment as part of its license agreement with Helsinn Healthcare for the development of ZP1846 for the treatment of chemotherapy-induced diarrhoea. This milestone payment has no impact on the Company's outlook for 2010.

9 Dec 2010

School-based intervention program helps students with asthma better manage symptoms

A school-based intervention program helped New York City high school students with moderate to severe asthma better manage their symptoms, dramatically reducing the need for urgent care, including hospitalizations and emergency room visits, according to a study published online in the American Journal of Respiratory and Critical Care Medicine.

9 Dec 2010

Firefly enzyme offers new medical imaging agent for blood clot detection

The enzyme that makes fireflies glow is lighting up the scientific path toward a long-sought new medical imaging agent to better monitor treatment with heparin, the blood thinner that millions of people take to prevent or treat blood clots, scientists are reporting. Their study appears in the ACS' monthly journal Bioconjugate Chemistry.

9 Dec 2010

Childhood maltreatment more strongly associated with current psychiatric symptoms than military sexual stressors

A study of long-term, active duty military personnel who used Department of Veterans Affairs' health services showed that childhood maltreatment and other high magnitude stressors, such as being in a serious accident or a natural disaster, were more strongly associated with participants' current psychiatric symptoms than were their military sexual experiences, such as sexual harassment.

9 Dec 2010

Research sheds new light on dopamine's role in brain's reward system

Researchers have shed new light on dopamine's role in the brain's reward system, which could provide insight into impulse control problems associated with addiction and a number of psychiatric disorders.

9 Dec 2010

New finding could help identify individuals with abnormal brain function

Mayo Clinic researchers found that the part of the brain generating seizures in individuals with epilepsy is functionally isolated from surrounding brain regions. The researchers hope this finding could be a clinical biomarker to help identify individuals with abnormal brain function.

9 Dec 2010

New report indicates that struggling economy may have reduced use of preventive care

A new report released by non-profit health care organization MN Community Measurement, indicates that the struggling economy may have reduced the use of preventive care, including breast cancer screenings and childhood immunizations, as well as the on-going care needed for chronic diseases like diabetes and vascular disease.

9 Dec 2010

Health care systems inadequate for managing acute GI hemorrhage outside of normal hours

Patients treated by Welsh hospitals for upper gastrointestinal (GI) bleeding were 41% more likely to die if they were admitted on a public holiday and 13% more likely if it was at the weekend, according to research in the January issue of Alimentary Pharmacology and Therapeutics.

9 Dec 2010

Results of proteomics study performed utilizing plasma samples from ADNI now available

The Foundation for the National Institutes of Health's Biomarkers Consortium announced today that the results of a proteomics study performed utilizing plasma samples from the Alzheimer's Disease Neuroimaging Initiative are ready to be shared with scientists worldwide for further analysis.

9 Dec 2010

Digestive Disease Specialists deploys Wolters Kluwer Health's ProVation MD software

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Digestive Disease Specialists, Inc. has selected its ProVation MD software for gastroenterology procedure documentation and coding.

9 Dec 2010

New study shows how meditators don't ponder pain

Zen meditation has many health benefits, including a reduced sensitivity to pain. According to new research from the Universit- de Montr-al, meditators do feel pain but they simply don't dwell on it as much. These findings, published in the month's issue of Pain, may have implications for chronic pain sufferers, such as those with arthritis, back pain or cancer.

9 Dec 2010

Researchers discover central switch that regulates movement of cancer cells

Researchers at the University of Georgia have discovered a central switch that controls whether cells move or remain stationary. The misregulation of this switch may play a role in the increased movement of tumor cells and in the aggressiveness of tumors themselves.

9 Dec 2010

Researchers to address HRQOL issues for pediatric patients with IBD at annual conference

The management of children with inflammatory bowel diseases such as Crohn's disease and ulcerative colitis has evolved significantly over the past decade. With a surge of pediatric research in the field, quality of life has become an important focus of study, as indicated by the number of related abstracts that will be presented at the 2010 Advances in Inflammatory Bowel Diseases, the Crohn's & Colitis Foundation's Clinical & Research Conference beginning tomorrow in Hollywood, Florida.

9 Dec 2010

Insulin related calls to poison centers increase 279%

Annual calls to poison centers regarding insulin have skyrocketed by 279 percent over the past 10 years, according to a new study authored by medical professionals at four U.S. poison centers.

9 Dec 2010

Rexahn presents data from Serdaxin Phase IIa study at 49th ACNP Annual Meeting

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the presentation of data from its proof of concept study with lead CNS compound Serdaxin® at the 49th American College of Neuropsychopharmacologists (ACNP) Annual Meeting, held in Miami Beach, FL, December 5-9, 2010 at the Fountainbleau Resort.

9 Dec 2010

New software predicts key information about nasal insulin treatment regimens in type 1 diabetes

A La Jolla Institute team, led by leading type 1 diabetes researcher Matthias von Herrath, M.D., has demonstrated the effectiveness of a recently developed computer model in predicting key information about nasal insulin treatment regimens in type 1 (juvenile) diabetes. Development of the software, the Type 1 Diabetes PhysioLab- Platform, was funded through the peer-reviewed grant program of the American Diabetes Association.

9 Dec 2010

Health2 Resources provides strategic research, analysis for ACCC project

The Association of Community Cancer Centers announced that results of a landmark study of how—and how well—the cancer patient's transition from the hospital inpatient setting to outpatient oncology group is managed. The study, designed to help hospitals and oncology groups improve their transition processes. The study was conducted by the Association of Community Cancer Centers, was conducted by ACCC, with strategic research and analysis provided by Health2 Resources.

9 Dec 2010

Systagenix launches new innovative website

Following the highly successful global launch of the new Corporate Identity, Systagenix has today unveiled its new innovative website - www.systagenix.com.

9 Dec 2010

Medical Condition News

Study to develop ways to track individual's exposure to traffic pollution

Collegium Ramazzini repeats calls for total global ban on all asbestos

Zealand receives EUR 500,000 milestone payment from Helsinn Healthcare for ZP1846 development program

School-based intervention program helps students with asthma better manage symptoms

Firefly enzyme offers new medical imaging agent for blood clot detection

Childhood maltreatment more strongly associated with current psychiatric symptoms than military sexual stressors

Research sheds new light on dopamine's role in brain's reward system

New finding could help identify individuals with abnormal brain function

New report indicates that struggling economy may have reduced use of preventive care

Health care systems inadequate for managing acute GI hemorrhage outside of normal hours

Results of proteomics study performed utilizing plasma samples from ADNI now available

Digestive Disease Specialists deploys Wolters Kluwer Health's ProVation MD software

New study shows how meditators don't ponder pain

Researchers discover central switch that regulates movement of cancer cells

Researchers to address HRQOL issues for pediatric patients with IBD at annual conference

Insulin related calls to poison centers increase 279%

Rexahn presents data from Serdaxin Phase IIa study at 49th ACNP Annual Meeting

New software predicts key information about nasal insulin treatment regimens in type 1 diabetes

Health2 Resources provides strategic research, analysis for ACCC project

Systagenix launches new innovative website

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News